← All Zentalis Pharmaceuticals, INC filings

Zentalis Pharmaceuticals, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
ZNTL
Zentalis Pharmaceuticals, INC
SCHEDULE: Matrix Capital Exits Zentalis Pharmaceuticals Stake
Matrix Capital Management and David E. Goel have completed an exit filing, reporting zero beneficial ownership in Zentalis Pharmaceuticals after a private sale of shares.
NASDAQ
ZNTL
Zentalis Pharmaceuticals, INC
SCHEDULE: Matrix Capital Reduces Zentalis Stake, Director Resigns
Matrix Capital Management Company, LP reduced its stake in Zentalis Pharmaceuticals, Inc. to 9.98% through a share repurchase, coinciding with a director's resignation.